Search results for "ACID"

showing 10 items of 13107 documents

Age-related changes in the endocannabinoid system in the mouse hippocampus.

2015

Previous studies have demonstrated that the endocannabinoid system significantly influences the progression of brain ageing, and the hippocampus is one of the brain regions most vulnerable to ageing and neurodegeneration. We have further examined age-related changes in the hippocampal endocannabinoid system by measuring the levels of anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in young and old mice from two different mouse strains. We found a decrease in 2-AG but not AEA levels in aged mice. In order to identify the cause for 2-AG level changes, we investigated the levels of several enzymes that contribute to synthesis and degradation of 2-AG in the hippocampus. We found a selective …

medicine.medical_specialtyAgingPolyunsaturated Alkamides2-ArachidonoylglycerolHippocampusmetabolism [Hippocampus]Arachidonic AcidsHippocampal formationBiologyHippocampusGlycerideschemistry.chemical_compoundMicepathology [Aging]Internal medicinemetabolism [Arachidonic Acids]medicineanandamideAnimalsglyceryl 2-arachidonateddc:610metabolism [Aging]NeurodegenerationAnandamidemedicine.diseasemetabolism [Endocannabinoids]Endocannabinoid systemMonoacylglycerol lipaseLipoprotein Lipasepathology [Hippocampus]metabolism [Polyunsaturated Alkamides]EndocrinologychemistryAgeingphysiopathology [Hippocampus]lipids (amino acids peptides and proteins)metabolism [Lipoprotein Lipase]metabolism [Glycerides]Developmental BiologyEndocannabinoidsMechanisms of ageing and development
researchProduct

The spectrum of allergic (cross-)sensitivity in clinical patch testing with 'para amino' compounds

2002

Background: Allergic contact sensitization to ‘para amino’ compounds is frequent and the spectrum of cross-reactivity between members of this chemical group is variable. Methods: A retrospective analysis of clinical patch test data obtained with a special test series in the centres of the Information Network of Departments of Dermatology (IVDK) between 1995 and 1999. Results: In the 638 patients tested with the above test panel positive reactions were observed most often to p-aminoazobenzene (16.2%), p-phenylenediamine (14.1%), p-toluylenediamine (10.0%), followed by 4,4′-diaminodiphenylmethane (8.5%), Disperse Orange 3 (8.4%) and p-aminophenol (3.1%). Among the 544 patients tested with p-p…

medicine.medical_specialtyAllergyConcordanceCross sensitivityStatistics as TopicImmunologyCross ReactionsPhenylenediaminesAminophenolsmedicine.disease_causeCross-reactivity030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compoundSulfanilamide0302 clinical medicineGermanySulfanilamidesmedicineHumansImmunology and AllergyAminesRetrospective Studiesbusiness.industryPatch testp-PhenylenediamineAllergensPatch Testsmedicine.diseaseDermatology3. Good healthchemistryP-Aminoazobenzenep-Aminoazobenzene030220 oncology & carcinogenesisDermatitis Allergic ContactImmunologybusiness4-Aminobenzoic AcidContact dermatitisAllergy
researchProduct

The L-glutamate transporters GLAST (EAAT1) and GLT-1 (EAAT2): expression and regulation in rat lactating mammary gland.

1999

The Na(+)-dependent L-glutamate transporters GLAST (EAAT1) and GLT-1 (EAAT2), were expressed in rat lactating mammary gland, but EAAC1 (EAAT3) was not. GLT-1 expression in rat lactating mammary gland was constant in all the physiological situations studied; however, the GLAST expression is under tight regulation. Fasting for 24 h decreased the GLAST expression which returned to control values after refeeding. Weaning for 24 h produced a decrease in GLAST expression through a mechanism independent of prolactin deficiency. Resuckling for 6 h returned the expression of this transporter to control values. There is a correlation between the levels of GLAST (mRNA and protein) and the in vivo upta…

medicine.medical_specialtyAmino Acid Transport System X-AGMammary glandBlotting WesternMammary Glands AnimalIn vivoInternal medicineLactationmedicineWeaningAnimalsLactationTissue DistributionRats WistarMolecular BiologyMessenger RNAChemistryReverse Transcriptase Polymerase Chain ReactionTransporterProlactin deficiencyCell BiologyBlotting NorthernRatsBlotmedicine.anatomical_structureEndocrinologyATP-Binding Cassette TransportersFemaleMolecular membrane biology
researchProduct

Fast Isolation by AFLP of Sequences Containing Repeats

2013

Fast isolation by AFLP of sequences containing repeats (FIASCO) is a rapid and simple method for separating microsatellite-containing DNA fragments from genomic DNA de novo. The method takes the advantage of the amplified fragment length polymorphism (AFLP) technique that relies on effective digestion-ligation reaction. The repeat-containing fragments are selectively hybridized to biotinylated probes and harvested by streptavidin-coated magnetic beads. The enriched microsatellite-containing fragments can be cloned and sequenced to yield a variety of microsatellite loci for applications in many different fields in molecular genetics.

medicine.medical_specialtyAmplified Fragment Length Polymorphism AnalysisComputational biologyBiologygenomic DNAchemistry.chemical_compoundNucleic acid thermodynamicschemistryMolecular geneticsmedicineDirect repeatMicrosatelliteAmplified fragment length polymorphismDNA
researchProduct

Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

2010

BACKGROUND Hereditary angioedema is characterized by recurrent attacks of angioedema of the skin, larynx, and gastrointestinal tract. Bradykinin is the key mediator of symptoms. Icatibant is a selective bradykinin B2 receptor antagonist. METHODS In two double-blind, randomized, multicenter trials, we evaluated the effect of icatibant in patients with hereditary angioedema presenting with cutaneous or abdominal attacks. In the For Angioedema Subcutaneous Treatment (FAST) 1 trial, patients received either icatibant or placebo; in FAST-2, patients received either icatibant or oral tranexamic acid, at a dose of 3 g daily for 2 days. Icatibant was given once, subcutaneously, at a dose of 30 mg. …

medicine.medical_specialtyAngioedemabusiness.industryGeneral MedicinePlacebomedicine.diseaseSurgerylaw.inventionEcallantidechemistry.chemical_compoundRandomized controlled trialchemistrylawIcatibantAnesthesiaHereditary angioedemamedicinemedicine.symptomBradykinin receptorbusinessTranexamic acidmedicine.drugNew England Journal of Medicine
researchProduct

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells

2012

Zoledronic acid (ZOL) is the most potent nitrogen-containing bisphosphonate (N-BPs) that strongly binds to bone mineral and acts as a powerful inhibitor of bone resorption, already clinically available for the treatment of patients with osteolytic metastases. Recent data also suggest that ZOL, used in breast cancer, may provide more than just supportive care modifying the course of the disease, though the possible molecular mechanism of action is still unclear. As breast cancer is one of the primary tumours with high propensity to metastasize to the bone, we investigated, for the first time, differential gene expression profile on Michigan Cancer Foundation-7 (MCF-7) breast cancer cells tre…

medicine.medical_specialtyAngiogenesismedicine.medical_treatmentBlotting WesternAngiogenesis InhibitorsAntineoplastic AgentsBreast NeoplasmsBiologyReal-Time Polymerase Chain ReactionZoledronic AcidZOL FN1 TGF-b1 THBS-1 invasion breast cancerBone resorptionThrombospondin 1Transforming Growth Factor beta1breast cancerBreast cancerTGF-β1Internal medicineThrombospondin 1medicineHumansBone ResorptionCell ProliferationMatrigelDiphosphonatesFN1Gene Expression ProfilingImidazolesCancerOriginal ArticlesCell BiologyZOLBisphosphonateMicroarray Analysisinvasionmedicine.diseaseFibronectinsUp-RegulationGene Expression Regulation NeoplasticEndocrinologyZoledronic acidTHBS-1MCF-7 CellsCancer researchMolecular MedicineFemalemedicine.drug
researchProduct

Anti-gout drugs as potential therapy for atrial fibrillation.

2014

Atrial fibrillation (AF) is an important cardiovascular disease in theelderly [1]. Noticeably, it has been increasingly demonstrated thatserum uric acid (UA) is associated with AF [2–9]. In a recent meta-analysis performed by Tamariz and coworkers, the authors concludedthat high levels of UA and AF are clearly associated [10]. Interestingly,serum UA has been linked to AF in obstructive sleep apnea patients[11], whereas it has been also associated with thromboembolic risk inpatients with nonvalvular AF [12].The treatment of gout, a metabolic disorder caused by chronic hyper-uricemia, is based on administration of colchicine, xanthine oxidase (XO)competitive inhibitors such as allopurinol, and…

medicine.medical_specialtyAnti-gout; atrial fibrillation; allopurinolAllopurinolSaludallopurinolGout Suppressantschemistry.chemical_compoundInternal medicineAtrial FibrillationMedicineColchicineHumansEducación físicaXanthine oxidaseCondición físicabusiness.industryMetabolic disorderAtrial fibrillationmedicine.diseaseEjercicio físicoGoutBlood pressurechemistryAnesthesiaAnti-goutCardiologyUric acidCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational journal of cardiology
researchProduct

Early postoperative substitution procedure of the antioxidant ascorbic acid.

2005

Postoperatively reduced concentration of ascorbic acid (AA) in plasma (or =45.5 micromol/l (or =800 microg/dl)) is commonly interpreted as increased metabolic requirements, but it is not shown yet that the patient benefits from a substitution toward normal levels of AA. This is due to the missing knowledge on how to substitute AA effectively to normal plasma values in postoperative patients. Therefore, a postoperative AA substitution procedure "overnight" to normal values in plasma was investigated on a postoperative intensive care unit (ICU) in a university hospital.Fifty-seven operated patients were randomly assigned to a control- or intervention group (CG and IG, respectively). In all pa…

medicine.medical_specialtyAntioxidantEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryIntervention groupNormal valuesAscorbic AcidBiochemistryGastroenterologyAntioxidantslaw.inventionlawInternal medicinePreoperative CareMedicineHumansMolecular BiologyPostoperative CareNutrition and Dieteticsbusiness.industryAscorbic acidUniversity hospitalIntensive care unitIntensive Care UnitsReduced concentrationAnesthesiaPlasma concentrationbusinessThe Journal of nutritional biochemistry
researchProduct

Diabetes mellitus: oxidative stress and wine.

2003

This review focuses on the link between diabetes mellitus and oxidative stress and, in particular, on the role that moderate wine consumption may play in preventing diabetic complications and the onset of diabetes. With this aim, a search of PubMed was carried out for literature published up to March 2003. In diabetes mellitus, oxidative stress results both from exposure to hyperglycaemia through glycoxidation and sorbitol system activation, and from functional limitation of the hexose monophosphate shunt, leading to a decrease in glutathione synthesis. Oxidative stress alters the plasma lipoprotein profile (particularly low-density lipoproteins), the coagulative parameters (with an increas…

medicine.medical_specialtyAntioxidantEndotheliumThiobarbituric acidmedicine.medical_treatmentWineType 2 diabetesmedicine.disease_causeAntioxidantsDiabetes Complicationschemistry.chemical_compoundDiabetes mellitusInternal medicineTBARSmedicineDiabetes MellitusHumansbusiness.industryGeneral Medicinemedicine.diseaseAscorbic acidOxidative Stressmedicine.anatomical_structureEndocrinologychemistrybusinessOxidative stressCurrent medical research and opinion
researchProduct

Ascorbic Acid in Postoperative Intensive Care Patients - Biochemical Aspects and Clinical Experience

2009

The transport mechanisms of ascorbic acid (AA) are described. The metabolism of AA and its function as an antioxidant are covered in some detail. Subsequently, indications for postoperative substitution are discussed. The supplementation of up to 300 mg of AA per day in postoperative intensive care unit patients during par-/enteral nutrition is recommended to prevent hypovitaminosis. It is not clear if this is the optimal dosage of AA in postoperative/-trauma patients. New aspects for an AA substitution are discussed.

medicine.medical_specialtyAntioxidantmedicine.medical_treatmentAscorbic AcidBiochemistryGastroenterologyAntioxidantslaw.inventionHypovitaminosislawInternal medicineIntensive careDrug DiscoveryHumansMedicinePostoperative CarePharmacologybusiness.industryOrganic ChemistryAscorbic acidIntensive care unitSurgeryParenteral nutritionWounds and InjuriesMolecular MedicinebusinessCurrent Medicinal Chemistry
researchProduct